Zanubrutinib for treating Waldenström's macroglobulinaemia [ID1427]: draft guidance
We are listening to your views on this Technology appraisal guidance. Comments close 26 May 2022.
We are listening to your views on this Technology appraisal guidance. Comments close 26 May 2022.
We are listening to your views on this Interventional procedures guidance. Comments close 24 May 2022.
We are listening to your views on this Technology appraisal guidance. Comments close 16 November 2021.
We are listening to your views on this Technology appraisal guidance. Comments close 6 June 2022.
We are listening to your views on this Medical technologies guidance. Comments close 16 June 2022.